The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004

Diagnostic Microbiology and Infectious Disease

Volumn 62, Issue 1, 2008, Pages 81-85

  Reik, Rebecca ^a   Tenover, Fred C ^b   Klein, Eili ^c   McDonald, L Clifford ^b  

^a EMORY UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c RESOURCES FOR THE FUTURE   (United States)

Author keywords

Burden; Enterococcus; Resistance; Vancomycin

Indexed keywords

VANCOMYCIN;

ABDOMINAL INFECTION; ARTICLE; CONTROLLED STUDY; ENTEROCOCCAL INFECTION; HOSPITAL; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UNITED STATES; URINARY TRACT; VANCOMYCIN RESISTANT ENTEROCOCCUS; WOUND INFECTION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALIZATION; HOSPITALS; HUMANS; PATIENT DISCHARGE; POPULATION SURVEILLANCE; UNITED STATES; URINARY TRACT INFECTIONS; VANCOMYCIN RESISTANCE; WOUND INFECTION;

EID: 49549094298     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.04.013     Document Type: Article

References (32)

1. American Medical Association. ICD-9-CM, 1996: International Classification of Diseases, 9th Revision, Clinical Modification Volumes 1 and 2 (1995)
2. Biedenbach D.J., Moet G.J., and Jones R.N. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn. Microbiol. Infect. Dis. 50 (2004) 59-69
3. Carmeli Y., Eliopoulos G., Mozaffari E., and Samore M. Health and economic outcomes of vancomycin-resistant enterococci. Arch. Intern. Med. 162 (2002) 2223-2228
4. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin-United States, 1989-1993. MMWR Morb. Mortal. Wkly. Rep. 42 (1993) 597-599
5. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm. Rep. 44 (1995) 1-13
6. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect. Control 32 (2004) 470-485
7. CLSI. Performance standards for antimicrobial susceptibility testing: sixteenth informational supplement. Document M100-S16 (2006), CLSI, Wayne, PA
8. Cosgrove S.E., and Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin. Infect. Dis. 36 (2003) 1433-1437
9. Deshpande L.M., Fritsche T.R., Moet G.J., Biedenbach D.J., and Jones R.N. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn. Microbiol. Infect. Dis. 58 (2007) 163-170
10. Dobbs T.E., Patel M., Waites K.B., Moser S.A., Stamm A.M., and Hoesley C.J. Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center. J. Clin. Microbiol. 44 (2006) 3368-3370
11. Edmond M.B., Ober J.F., Dawson J.D., Weinbaum D.L., and Wenzel R.P. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin. Infect. Dis. 23 (1996) 1234-1239
12. Eliopoulos G.M. Quinupristin-dalfopristin and linezolid: evidence and opinion. Clin. Infect. Dis. 36 (2003) 473-481
13. Goldstein E.J., and Snydman D.R. Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy. J. Antimicrob. Chemother. 53 Suppl 2 (2004) ii29-ii36
14. Gordon K.A., and Jones R.N. Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000). Diagn. Microbiol. Infect. Dis. 45 (2003) 295-301
15. Huang S.S., Rifas-Shiman S.L., Pottinger J.M., Herwaldt L.A., Zembower T.R., Noskin G.A., Cosgrove S.E., Perl T.M., Curtis A.B., Tokars J.L., Diekema D.J., Jernigan J.A., Hinrichsen V.L., Yokoe D.S., and Platt R. Improving the assessment of vancomycin-resistant enterococci by routine screening. J. Infect. Dis. 195 (2007) 339-346
16. Jones M.E., Karlowsky J.A., Draghi D.C., Thornsberry C., Sahm D.F., and Nathwani D. Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy. Int. J. Antimicrob. Agents 22 (2003) 406-419
17. Jones M.E., Draghi D.C., Thornsberry C., Karlowsky J.A., Sahm D.F., and Wenzel R.P. Emerging resistance among bacterial pathogens in the intensive care unit-a European and North American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob 3 (2004) 14
18. Jones R.N., Marshall S.A., Pfaller M.A., Wilke W.W., Hollis R.J., Erwin M.E., Edmond M.B., and Wenzel R.P. Nosocomial enterococcal blood stream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study Group. Diagn. Microbiol. Infect. Dis. 29 (1997) 95-102
19. Karlowsky J.A., Jones M.E., Draghi D.C., Thornsberry C., Sahm D.F., and Volturo G.A. Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002. Ann. Clin. Microbiol. Antimicrob. 3 (2004) 7
20. Klein E., Smith D.L., and Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg. Infect. Dis. 13 (2007) 1840-1846
21. Kozak L.J., Owings M.F., and Hall M.J. National Hospital Discharge Survey: 2001 annual summary with detailed diagnosis and procedure data. Vital Health Stat. 13 156 (2004) 1-198
22. Kuehnert M.J., Hill H.A., Kupronis B.A., Tokars J.I., Solomon S.L., and Jernigan D.B. Methicillin-resistant-Staphylococcus aureus hospitalizations, United States. Emerg. Infect. Dis. 11 (2005) 868-872
23. Leclercq R., Derlot E., Duval J., and Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319 (1988) 157-161
24. McDonald L.C., Owings M., and Jernigan D.B. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg. Infect. Dis. 12 (2006) 409-415
25. Murray B.E. Vancomycin-resistant enterococcal infections. N. Engl. J. Med. 342 (2000) 710-721
26. National Center for Health Statistics (U.S.). National Hospital Discharge Survey 2003 (2005). http://www.cdc.gov/nchs/about/major/hdasd/nhds.htm Last accessed Jan 23, 2008
27. Ollendorf D.A., Fendrick A.M., Massey K., Williams G.R., and Oster G. Is sepsis accurately coded on hospital bills?. Value Health 5 (2002) 79-81
28. Sahm D.F., Thornsberry C., and Karlowsky J.A. The application of information technology to regional, national, and global surveillance of antimicrobial resistance. Curr. Pharm. Des. 9 (2003) 969-974
29. Seedat J., Zick G., Klare I., Konstabel C., Weiler N., and Sahly H. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection. Antimicrob. Agents Chemother. 50 (2006) 4217-4219
30. US Census Bureau. Census 2001 Geographic Definitions (2001). http://www.census.gov/geo/www/geo_defn.html#AttachmentC Last accessed Apr 20, 2008
31. Uttley A.H., George R.C., Naidoo J., Woodford N., Johnson A.P., Collins C.H., Morrison D., Gilfillan A.J., Fitch L.E., and Heptonstall J. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol. Infect. 103 (1989) 173-181
32. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., and Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39 (2004) 309-317